Single-Use Bioprocessing - Global Strategic Business Report

The global market for Single-Use Bioprocessing was estimated at US$21.5 Billion in 2023 and is projected to reach US$80.8 Billion by 2030, growing at a CAGR of 20.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Single-Use Bioprocessing Market - Key Trends and Drivers Summarized

Why Is Single-Use Bioprocessing Gaining Momentum in the Biopharmaceutical Industry?

Single-use bioprocessing is gaining momentum in the biopharmaceutical industry due to its cost-effectiveness, flexibility, and scalability, which are crucial for meeting the growing demand for biologics, vaccines, and cell and gene therapies. Unlike traditional stainless-steel bioprocessing systems, single-use systems (SUS) use disposable components such as bags, tubing, connectors, and filters, which significantly reduce the risk of cross-contamination, cleaning validation, and downtime. This flexibility is particularly beneficial for small-scale and multi-product manufacturing facilities, where quick changeovers, faster turnaround times, and lower capital investment are key advantages. As biopharma companies increasingly seek efficient and agile production solutions to accelerate time to market, single-use bioprocessing is becoming a preferred choice across upstream, downstream, and fill-finish operations.

How Are Technological Advancements Driving Innovation in Single-Use Bioprocessing?

Technological advancements are driving innovation in single-use bioprocessing by improving the performance, reliability, and integration of single-use systems. The development of high-efficiency, automated, and scalable single-use bioreactors, mixers, and filtration systems is enabling more robust and consistent biomanufacturing processes. Innovations in disposable sensors, connectors, and assemblies are enhancing process monitoring, control, and data integrity, making single-use bioprocessing more efficient and user-friendly. The integration of single-use systems with continuous bioprocessing, modular facilities, and digital solutions is further optimizing biomanufacturing by reducing costs, improving yield, and ensuring regulatory compliance. These advancements are not only enhancing the capabilities of single-use bioprocessing but also addressing the challenges related to scale-up, leachables, extractables, and waste management.

Which Market Segments Are Leading the Adoption of Single-Use Bioprocessing?

Products include single-use bioreactors, filtration assemblies, mixers, bags, tubing, and sensors, with single-use bioreactors being one of the most widely used due to their ability to provide efficient and flexible biomanufacturing solutions. Applications of single-use bioprocessing span monoclonal antibody production, vaccine production, cell and gene therapy, and biosimilars, with monoclonal antibody production leading the market due to the high demand for biologics. End-users include biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic and research institutions, with biopharmaceutical companies being the primary adopters due to their focus on cost-effective and scalable production processes. Geographically, North America and Europe are the largest markets for single-use bioprocessing due to strong biopharma infrastructure, technological advancements, and regulatory support, while Asia-Pacific is emerging as a high-growth region driven by expanding biopharma capacity and increasing investments in biologics.

What Are the Key Drivers of Growth in the Single-Use Bioprocessing Market?

The growth in the single-use bioprocessing market is driven by several factors, including the rising demand for flexible, scalable, and cost-effective biomanufacturing solutions, technological advancements in high-efficiency and automated single-use systems, and the increasing use of single-use technologies in monoclonal antibody production, vaccine development, and cell and gene therapy. The development of customizable, integrated, and modular single-use bioprocessing platforms is driving market adoption among biopharmaceutical companies, CDMOs, and academic institutions. The focus on reducing cross-contamination, cleaning validation, and downtime is expanding the market reach among multi-product, small-scale, and flexible manufacturing facilities. The growing use of single-use systems in upstream, downstream, and fill-finish operations, coupled with the demand for eco-friendly, recyclable, and sustainable solutions, is creating new opportunities for market growth. Additionally, the increasing investments in R&D for innovative, disposable sensors, connectors, and assemblies are further supporting market expansion.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Single-Use Media Bags & Containers segment, which is expected to reach US$29.9 Billion by 2030 with a CAGR of a 22.6%. The Single-Use Assemblies segment is also set to grow at 21.3% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, which was estimated at $5.8 Billion in 2023, and China, forecasted to grow at an impressive 19.3% CAGR to reach $11.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Single-Use Bioprocessing Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Single-Use Bioprocessing Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Single-Use Bioprocessing Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as 3M Company, Applikon Biotechnology BV, Cesco Bioengineering Co. Ltd., and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 47 Featured):

• 3M Company
• Applikon Biotechnology BV
• Cesco Bioengineering Co. Ltd.
• Danaher Corporation
• Eppendorf AG
• GE Healthcare
• Thermo Fisher Scientific, Inc.